Home Countdown to 2023 Changping Healthcare Innovative Financial Investment Forum: A Comprehensive Attendee Guide

Countdown to 2023 Changping Healthcare Innovative Financial Investment Forum: A Comprehensive Attendee Guide

Nov 14, 2023 12:11 CST Updated 12:11
VBEF

Government, Park, and Healthcare Industry Service Providers

In recent years, Beijing has attached great importance to the development of the biopharmaceutical industry. In accelerating the construction of an international center for scientific and technological innovation, it has focused on key areas such as scientific and technological innovation, biopharmaceuticals, and the digital economy, achieving remarkable results. As a crucial hub for Beijing’s International Center for Scientific and Technological Innovation and a highland for innovation in the city’s pharmaceutical and health industries, Changping District is actively building multi-channel, multi-tiered enterprise service platforms to continuously promote institutional innovation and supply chain openness in the biopharmaceutical sector.


On November 17, 2023, in the lecture hall on the first floor of Taikang Research Institute, Changping, Beijing,To Be HeldbyHosted by the People's Government of Changping District, Beijing; co-organized by the Administrative Committee of Future Science City (Life Science Park Administrative Committee), the Administrative Committee of Zhongguancun Science Park Changping Park, the Financial Services Office of Changping District, Beijing, Beijing Changping Science Park Development Co., Ltd., Beijing Zhongguancun Life Science Park Development Co., Ltd., and VCBeat VB100.The 2023 Changping Medical and Health Investment Innovation Forum will leverage Changping District’s unique industrial and financial resource advantages, inviting nearly 50 distinguished guests from the medical and health ecosystem—including government officials, academicians and scientists, clinical experts, top-tier investors, and corporate leaders—along with over 400 high-level industry professionals to explore value investment and value creation in the future pharmaceutical and healthcare industries.


2023昌平医药健康金融投资创新论坛-活动主K_画板 1.png




Guide in Hand, Worry-Free Attendance




Forum Time: November 17, 2023 09:00-18:00

Forum Venue: Lecture Hall, 1st Floor, Taikang Institute of Research (No. 12 Shengmingyuan Road, Zhongguancun Life Science Park, Changping District, Beijing)


Conference Check-in

Registration Time: November 17, 2023, 08:00-09:30

Check-in Location: Lecture Hall, 1st Floor, Taikang Institute of Learning (The south gate is closer to the venue)

Check-in Method 1: Attendees who have registered online may proceed to the on-site check-in desk. Scan the QR code or verify your identity using your name and phone number to complete registration and attend the conference.

Check-in Method 2: Attendees who have not pre-registered may register on-site at the check-in desk to complete their registration and attend the conference.

(Gentle Reminder: To avoid overcrowding and traffic congestion, we recommend that you plan your travel in advance and arrive at the venue early. The first 50 attendees to check in will receive a complimentary gift. Additionally, meal vouchers are limited and available on a first-come, first-served basis.)


小程序报名码.png

Free Registration


Meal Reminder

Lunch Time: November 17, 12:00-13:00 (Please note the dining hours on your meal voucher and dine during off-peak hours.

Lunch Venue: Banquet Hall, 1st Floor, Taikang Institute

(Reminder: Meal vouchers are required for dining. They will become invalid after the expiration date, so please use them in time. Vouchers are limited in quantity; please keep them safe, as lost vouchers will not be replaced.)


Transportation Guide

Aircraft

● Beijing Capital International Airport

Public Transportation: Capital Airport Express Line → Line 10 (Outer Loop) → Changping Line → Bus Routes 871/878 (approximately 2 hours in total)

Taxi: Approximately 1 hour, around CNY 80


● Beijing Daxing International Airport

Public Transportation: Beijing Daxing International Airport Express → Line 19 → Line 10 (Outer Loop) → Changping Line → Bus Route 871/878 (approximately 2 hours in total)

Taxi: approximately 1 hour and 40 minutes, around CNY 210


High-Speed Rail (Train)

● Beijing West Railway Station

Public Transportation: Line 9 → Line 4 (Daxing Line) → Line 10 (Inner Loop) → Line 13 → Bus 521 (approx. 1 hour 30 minutes)

Taxi: Approximately 50 minutes, around RMB 70

● Beijing South Railway Station

Public Transportation: Line 4 Daxing Line → Line 13 → Changping Line → Bus 871/878 (approx. 1 hour 30 minutes)

Taxi: Approximately 1 hour and 10 minutes, around RMB 90

● Beijing Station

Public Transportation: Line 2 Inner Loop – Line 13 to Changping Line – Bus 521 (Total time: 1 hour 40 minutes)

Taxi: Approximately 1 hour, around RMB 80


Driving Navigation

Navigation & Parking: Locate to"South Gate of Taikang Research Institute, Zhongguancun Life Science Park"Enter the underground parking lot and mention “2023 Changping Medical and Health Financial Investment Innovation Forum” to enjoy free parking.Event signage is posted at the park entrance and parking areas to guide attendees to the conference venue.




Forum Highlights: Don't Miss the Excitement


Distinguished Experts Convene to Discuss Basic Research, Original Innovation, and the Future of Industry

This forum has invited government officials, academicians from professional societies, key executives from stock exchanges, clinical scholars in the domestic pharmaceutical and healthcare sectors, healthcare institution administrators, representatives from listed companies, innovators from emerging enterprises, and delegates from renowned financial investment institutions. By converging cutting-edge research insights and exploring industrial investment trends, participants will jointly discuss the new future of the pharmaceutical and healthcare industry.


Precise Data: Insights into the 2023 Global Healthcare Industry Trends

“2023 Global Healthcare Industry Capital Report” will be prominently released at the forum and interpreted on-site by VCBeat experts. Based on global healthcare information archived in VBInsight, the report cleanses over 42,000 financing data entries to substantiate the changing trends of the global healthcare industry in 2023 with authentic investment and financing data, helping industry practitioners gain insights into capital shifts. Against the backdrop of emerging technologies entering the market, global demographic structural adjustments, ongoing regional international conflicts, upstream supply chain shortages, and medical institutions’ efforts to reduce costs and improve efficiency, the report focuses on analyzing data across dimensions such as highlighted healthcare sectors, financing stages, popular cities/industrial clusters for investment and financing, and active healthcare investment institutions. It also forecasts trends in pharmaceutical and healthcare investment and financing, aiming to provide investment references for the industry.


Focusing on Hot Sectors, Envisioning the New Future of the Industry

This forum will feature four roundtable discussions with 28 guest speakers, who will delve into development trends and investment hotspots in niche sectors across four thematic sessions: “Innovative Pharmaceuticals,” “Innovative Medical Devices,” “Industry Ecosystem,” and “Capital Perspectives.” Below are the selected topics for these four roundtables.

● What is the significance of source innovation and achievement transformation for the innovative drug industry? Can the quantity and capability of indigenous scientific source innovation in China support the next era of new drug development?

● What are the new changes and trends in China’s medical device industry? Regarding the challenging issue of Chinese medical device companies breaking into overseas markets, what similar or differing recommendations do enterprises and investment institutions offer?

● Against the backdrop of requirements for high-quality corporate development, how can industrial parks and accelerators coordinate the needs of diverse stakeholders? How can they build more attractive and competitive service models?

● Amid a volatile and complex macroeconomic environment, how can investors distinguish between what is “changing” and what remains “unchanged”? Beyond capital investment, what other positive and constructive roles can investment institutions play?




Forum Agenda Updated Again: Get the Latest Insights First


09:30-09:50

▸ Forum Address

09:50-10:20

▸ Synthetic Biology and Biomanufacturing

Zhang Xian’en | Vice Chairman of the Chinese Society for Biotechnology, Director of the Synthetic Biology Branch

10:20-10:40

▸ Introduction to the BSE’s “19 Measures for Deepening Reform”

V. Yun| Director, Beijing Stock Exchange

10:40-11:00

▸ Leveraging the Advantages of Insurance Capital to Support Innovative Development in the Medical, Elderly Care, and Health Industries

Chen Youtang | Deputy Secretary-General of the Insurance Asset Management Association of China

11:00-11:40

▸ The Role of Basic Research and Original Innovation in Driving Industrial Development

Gao Dapeng | Executive Director and General Manager of Joinn Laboratories

Li Qian | Chairman of Sunshine Noah

Liu Guoen | Dean of the Institute for Global Health Development at Peking University, Member of the Division of the Chinese Academy of Medical Sciences

Xiao Zhi | Co-Head of the Life Sciences Team at SDIC Merchants, Managing Director

11:40-12:00

▸ 2023 Global Healthcare Industry Capital Report

Bi Yuanfeng | Co-founder and COO of VCBeat

12:00-14:00

▸ Lunch Break


14:00-15:00

▸ Strategies for Chinese Innovative Pharmaceutical Companies to Balance Breakthroughs and Stability for Long-Term Development Against the Backdrop of Strengthening Source Innovation and Achievement Commercialization

Roundtable Moderator: Gao Jieliang | Senior Partner, CDH Innovation & Growth Fund

Roundtable Panelists:

Li Qichen | Co-founder and General Manager of ImmuneOnco

Shang Yuanfang | Founder and CEO of CellBridge Bio

Tian Wenzhi | Chairman, CEO and CSO of ImmuneOnco

Xu Qian | General Manager and Managing Partner, Danlu Capital Beijing

Yang Bin | Director, Center for Smart Health, Institute for Precision Medicine, Tsinghua University

Zhang Yi | Managing Partner, Early-Stage Fund, Huagai Capital

15:00-16:00

▸ Strategies for Chinese Medical Device Companies to Break the Ice Amidst Great Power Competition

Roundtable Moderator: Tang Haofu | Partner, Chongqing Dianshi Chuangjian Fund / Shanghai Chuangrui Fund

Roundtable Panelists:

Liu Hongmei | Deputy General Manager of Huapu Keyi

Jie Jing |CTO of Weimai Medical

Yi Hongxiang | Partner, Shenzhen Capital Group’s Hongtu Healthcare Industry Fund

Zhang Yiling | Chairman of Changmugu

Zhou Yixin | Director of the Department of Orthopedic Surgery, Beijing Jishuitan Hospital, Capital Medical University; Professor at Peking University and Capital Medical University; Doctoral Supervisor

Zhu Zhicheng | Deputy General Manager of Jiuyiyuan

16:00-17:00

▸ Pathways for Service and Operation Agencies to Enhance Performance Under the Requirements of High-Quality Industrial Park Development

Roundtable Moderator: Li Yang | Head of Yuanyi Digital Health Accelerator

Roundtable Panelists:

Kang Haihua | Senior Managing Director of Kangqiao Capital and CEO of the Kangqiao Medical and Health Industry Facilities Platform

Wang Hui | Founder of Hongrun Health Group

Zang Dongning | Vice President, Clinical Development, Thermo Fisher Scientific China

Zhao Weiwen | General Manager, BGI Blue Rainbow Life Sciences Accelerator

Zheng Xiaoyu | Executive Dean of Beijing Gaobo Hospital and Beijing Gaobo Boren Hospital

Zhuang Jia | Head of ATLATL Innovation Department, Executive Director of ATLATL Venture Capital

17:00-18:00

▸ The Path to Survival for Capital and the Pharmaceutical Industry in a Complex Macroeconomic Environment

Roundtable Moderator: Tao Yu | Executive General Manager, Changkejin Company

Roundtable Guests:

Li Fan | Fosun Global Partner, CEO of FJ Capital

Li Jiangfeng | Partner at Fortune Capital

Liu Yu | General Manager and Managing Partner, BGI Win-Win

Liu Jiayun | Partner at Yahui Investment

Zhao Gang | Partner, SoftBank China Capital

Zheng Yufen | Founder and Chairman of Yueyin Medical Fund




Focusing on Tech-Finance to Empower New Tracks in Healthcare


2023昌平医药健康金融投资创新论坛-活动主K_画板 1.png

Forum Name:2023 Changping Pharmaceutical and Health Financial Investment Innovation Forum

Forum Schedule:November 17, 2023 09:00-18:00

Forum Venue:Lecture Hall, 1st Floor, Taikang Academy, Changping, Beijing

Forum Scale:300-400 people

Forum Organizing Committee:

· Organizer:

People's Government of Changping District, Beijing Municipality

· Organizer:

Administrative Committee of Future Science City (Administrative Committee of Life Science Park)

Administrative Committee of Changping Park, Zhongguancun Science Park

Financial Services Office of Changping District, Beijing

Beijing Changping Science Park Development Co., Ltd.

Beijing Zhongguancun Life Science Park Development Co., Ltd.

Beijing Danhuang Technology Co., Ltd. (VCBeat VB100)


· Forum Registration ·

昌平小程序报名码 (2).png

Scan the QR Code to Register for Free

Ticket Benefits:

1. Includes the report released at this forum (electronic version)

2. On-site Resource Coordination Group

3. Excerpts from Guest Speeches and Roundtable Discussions at the Forum

4. Forum Lunch Voucher

·Partner Media·


d7756a2a459edb4b107e33193986972.png


·Contact Us·

Conference Inquiry: [VB100] Ms. Peng - 13364027163 (WeChat ID same as phone number)

Media Partnership: [VB100] Ms. Zou - 15213067481 (WeChat ID same as phone number)